Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A randomised controlled trial to determine whether family centred structured education improves blood glucose control in adolescents with type 1 diabetes
Source of recordUK Trials
ISRCTNISRCTN89756583
Date ISRCTN assigned10/03/2008
Local reference number(s)Version 1.0 23 April 2007
Public titleA randomised controlled trial to determine whether family centred structured education improves blood glucose control in adolescents with type 1 diabetes
Scientific title
AcronymFACTS 2 - Family's and Adolescent's Communication and Teamwork Study
Disease/condition/study domainType 1 diabetes
Study hypothesisDoes structured education with family communication training help adolescents with type 1 diabetes to improve blood glucose control?

FACTS 1 study results in http://www.ncbi.nlm.nih.gov/pubmed/17894831
Design/methodologyRandomised controlled trial
Research ethics reviewApproved by the Suffolk Research Ethics Committee (REC) on 15 August 2007 (ref: 07/H0307/67)
Countries of trialUnited Kingdom
Participants - inclusion criteriaAdolescents with type 1 diabetes aged 11-16 years old
Participants - exclusion criteriaSerious medical or psychological co-morbidity which would limit ability to participate in the group education sessions.
Patient information material
Anticipated start date24/10/2007
Anticipated end date01/09/2010
Status of trialOngoing
Target number of participants300
InterventionsFamily centred structured education programme (intervention) vs standard outpatient care (control)

The key activities of the programme are:
6 x 90 min small group sessions at monthly intervals over 6 months with parents and adolescents seen together. It includes a combination of skills based and family-communication based sessions addressing blood glucose monitoring, food flexibility, insulin dose adjustment, hypoglycaemia, sports, school issues, challenges during adolescence, family communication and conflict resolution. It has a written philosophy and curriculum with a programme for training and quality development of the educators.
Primary outcome measure(s)Glycaemic control (HbA1c) at 12 months follow-up
Secondary outcome measure(s)1. Frequency of hypoglycaemia. Duration of follow-up: 12 months
2. Quality of Life and Family Responsibility questionnaire measures (Paediatric Quality of Life Inventory [PedsQL], Diabetes Family Responsibility [DFRQ], Problem Areas in Diabetes [PAID]) at 6 months
Sources of fundingDiabetes UK
Sponsor nameThe Ipswich Hospital NHS Trust (UK)
Sponsor detailsHeath Road
Ipswich
United Kingdom
IP4 5PD
Sponsor telephone+44 1473 704343
Sponsor emailresearch.office@ipswichhospital.nhs.uk
Sponsor websitehttp://www.ipswichhospital.org.uk/
Contact nameDr Helen Murphy
Contact detailsDiabetes Centre
Heath Road
Ipswich
United Kingdom
IP4 5PD
Contact telephone+44 1473 704759
Contact emailhelen.murphy@ipswichhospital.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN89756583
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central